189 related articles for article (PubMed ID: 27100445)
1. Rapidly Progressive Polyneuropathy in a Patient With Monoclonal Gammopathy: A Case Report of POEMS Syndrome and Beyond.
Wang C; Guan YZ; Cai QQ; Su W; Zhou DB; Li J
Medicine (Baltimore); 2016 Apr; 95(16):e3453. PubMed ID: 27100445
[TBL] [Abstract][Full Text] [Related]
2. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Ordway S; Gilbert L; Wanko S
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
[TBL] [Abstract][Full Text] [Related]
3. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
4. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
5. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
6. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
7. POEMS syndrome: complex factors contributing to a delayed diagnosis.
Robey RC; Campus C; Ringuette B; Shumate M
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26621905
[TBL] [Abstract][Full Text] [Related]
8. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
Isose S; Misawa S; Kanai K; Shibuya K; Sekiguchi Y; Nasu S; Fujimaki Y; Noto Y; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):678-80. PubMed ID: 20562460
[TBL] [Abstract][Full Text] [Related]
9. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
11. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
12. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
13. Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report.
Hara D; Akiyama H; Nukui S; Shimizu T; Hoshikawa M; Hasegawa Y
Medicine (Baltimore); 2017 Oct; 96(41):e8188. PubMed ID: 29019884
[TBL] [Abstract][Full Text] [Related]
14. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
15. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].
Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C
Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
17. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
Kuwabara S
Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
[TBL] [Abstract][Full Text] [Related]
18. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.
Kuwabara S; Dispenzieri A; Arimura K; Misawa S; Nakaseko C
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD006828. PubMed ID: 22696361
[TBL] [Abstract][Full Text] [Related]
19. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Tsuneyama A; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neurol Sci; 2020 Jun; 413():116771. PubMed ID: 32172013
[TBL] [Abstract][Full Text] [Related]
20. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
